duloxetine hydrochloride has been researched along with Cephalgia Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Volpe, FM | 1 |
| Artemenko, AR; Filatova, EG; Kurenkov, AL | 1 |
1 trial(s) available for duloxetine hydrochloride and Cephalgia Syndromes
| Article | Year |
|---|---|
An 8-week, open-label trial of duloxetine for comorbid major depressive disorder and chronic headache.
Topics: Adolescent; Adult; Antidepressive Agents; Brazil; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Headache Disorders; Humans; Male; Middle Aged; Pain Measurement; Personality Inventory; Prognosis; Quality of Life; Thiophenes | 2008 |
1 other study(ies) available for duloxetine hydrochloride and Cephalgia Syndromes
| Article | Year |
|---|---|
[Efficacy of duloxetine in the treatment of chronic daily headache].
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Follow-Up Studies; Headache Disorders; Humans; Male; Middle Aged; Pain Measurement; Pain Threshold; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Thiophenes; Treatment Outcome | 2007 |